Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2022 Filed Aug 30, 2022 13:17 UTC |
Merchant Minh HoangGeneral Counsel & Secretary
|
PurchaseCommon Stock | 26,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001936532-22-000002 · primary_doc.xml · nonDerivative · entry 1 Merchant Minh Hoang · CIK 0001936532 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,667 F1 · price: Each share of common stock was purchased together with one warrant to purchase one share of common stock (each share and related warrant, a "unit"), at a price of $0.75 per unit. Read SEC document |
| August 01, 2022 Filed Aug 1, 2022 20:37 UTC |
Sandford NicoleDirector · President and CEO
|
GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 5,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001849521-22-000008 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: COMMON STOCK · 5,000 shares Expires 2032-08-01 Read SEC document |
| July 05, 2022 Filed Jul 12, 2022 20:35 UTC |
Phan Ryan ThinhCSO & COO
|
GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 200,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001937660-22-000002 · primary_doc.xml · derivative · entry 1 Phan Ryan Thinh · CIK 0001937660 · CSO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: COMMON STOCK · 200,000 shares Expires 2032-07-05 F1 · derivative.exercise_date: The employee stock option will vest quarterly over two years in eight equal installments starting on October 1, 2022 and ending on 7/1/2024. Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:27 UTC |
Sandford NicoleDirector · President and CEO
|
GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 5,000 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001849521-22-000007 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: COMMON STOCK · 5,000 shares Expires 2032-07-01 Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 20:49 UTC |
Auerbach Robert DDirector
|
GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 83,799 | $0.00 Strike: $0.52 | $0.00 |
DisclosureSEC source: 0001745856-22-000002 · primary_doc.xml · derivative · entry 2 Auerbach Robert D · CIK 0001745856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,799 Underlying: COMMON STOCK · 83,799 shares Expires 2032-06-23 F2 · derivative.exercise_date: The employee stock option will vest in two equal installments on September 1, 2022 and December 1, 2022. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 20:49 UTC |
Auerbach Robert DDirector
|
GrantCommon Stock | 54,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001745856-22-000002 · primary_doc.xml · nonDerivative · entry 1 Auerbach Robert D · CIK 0001745856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,825 F1 · shares: The restricted stock units will vest in two equal installments on September 1, 2022 and December 1, 2022. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 20:20 UTC |
Sharma RubyDirector
|
GrantCommon Stock | 114,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001880428-22-000004 · primary_doc.xml · nonDerivative · entry 1 Sharma Ruby · CIK 0001880428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,218 F1 · shares: (1) The restricted stock units will vest in two equal installments on September 1, 2022 and December 1, 2022. Read SEC document |
| June 01, 2022 Filed Jun 1, 2022 21:26 UTC |
Sandford NicoleDirector · President and CEO
|
GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 5,000 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001849521-22-000006 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: COMMON STOCK · 5,000 shares Expires 2032-06-01 Read SEC document |
| May 16, 2022 Filed May 17, 2022 21:02 UTC |
Sandford NicoleDirector · President and CEO
|
PurchaseCommon Stock | 98,000 | $0.76 | $74,891.60 |
DisclosureSEC source: 0001849521-22-000005 · primary_doc.xml · nonDerivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,160 F1 · price: The purchase price reported in column 4 is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.745 to $0.779 per share. The reporting person undertakes to provide to Aspira Women's Health Inc., any security holder of Aspira Women's Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote. Read SEC document |
| May 16, 2022 Filed May 18, 2022 13:22 UTC |
Palmieri Valerie BarberDirector · Executive Chair
|
PurchaseCommon Stock | 43,994 | $0.57 | $24,918.20 |
DisclosureSEC source: 0001623017-22-000001 · primary_doc.xml · nonDerivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,088 F1 · price: The purchase price reported in column 4 is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.4928 to $0.6000 per share. The reporting person undertakes to provide to Aspira Women's Health Inc., any security holder of Aspira Women's Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote. Read SEC document |
| May 02, 2022 Filed May 3, 2022 20:37 UTC |
Sandford NicoleDirector · President and CEO
|
GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 5,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001849521-22-000004 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: COMMON STOCK · 5,000 shares Expires 2032-05-02 Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 22:57 UTC |
Sandford NicoleDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001849521-22-000003 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-04-01 Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 00:44 UTC |
Jordan Veronica GHDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 93,977 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001381123-22-000001 · primary_doc.xml · derivative · entry 3 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,977 Underlying: Common Stock · 93,977 shares Expires 2032-03-31 F2 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 00:44 UTC |
Jordan Veronica GHDirector
|
GrantCommon Stock | 11,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001381123-22-000001 · primary_doc.xml · nonDerivative · entry 2 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,175 F1 · shares: The restricted stock units will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 00:44 UTC |
Jordan Veronica GHDirector
|
GrantCommon Stock | 62,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001381123-22-000001 · primary_doc.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,659 F1 · shares: The restricted stock units will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 00:29 UTC |
Fralick Celeste RachelleDirector
|
GrantCommon Stock | 99,671 | $0.00 | $0.00 |
DisclosureSEC source: 0001911051-22-000002 · primary_doc.xml · nonDerivative · entry 1 Fralick Celeste Rachelle · CIK 0001911051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,671 F1 · shares: The restricted stock units will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 00:23 UTC |
LAFRANCE JAMES TDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 110,305 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001162956-22-000001 · primary_doc.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,305 Underlying: Common Stock · 110,305 shares Expires 2032-03-31 F2 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 00:23 UTC |
LAFRANCE JAMES TDirector
|
GrantCommon Stock | 72,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001162956-22-000001 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,129 F1 · shares: The restricted stock units will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:30 UTC |
Sandford NicoleDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001849521-22-000002 · primary_doc.xml · derivative · entry 2 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-03-31 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 31, 2023. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:30 UTC |
Sandford NicoleDirector · President and CEO
|
GrantCommon Stock | 23,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001849521-22-000002 · primary_doc.xml · nonDerivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,435 F1 · shares: The restricted stock units will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:16 UTC |
Beechey Robert HarryChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001725914-22-000002 · primary_doc.xml · derivative · entry 1 Beechey Robert Harry · CIK 0001725914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2032-03-31 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 31, 2023. Read SEC document |
| March 01, 2022 Filed Mar 1, 2022 21:38 UTC |
Sandford NicoleDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001849521-22-000001 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-03-01 Read SEC document |
| June 24, 2021 Filed Sep 16, 2021 22:14 UTC |
LAFRANCE JAMES TDirector
|
GrantEmployee Stock Option (Right To Buy) · Derivative | 502 | $0.00 Strike: $5.90 | $0.00 |
DisclosureSEC source: 0001162956-21-000003 · primary_doc.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502 Underlying: Common Stock · 502 shares Expires 2031-06-24 F2 · derivative.exercise_date: The employee stock option will vest in two equal installments on September 1, 2021 and December 1, 2021 Read SEC document |
| June 24, 2021 Filed Sep 16, 2021 22:14 UTC |
LAFRANCE JAMES TDirector
|
GrantCommon Stock | 330 | $0.00 | $0.00 |
DisclosureSEC source: 0001162956-21-000003 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,192 F1 · shares: The restricted stock units will vest in two equal installments on September 1, 2021 and December 1, 2021. Read SEC document |
| May 06, 2021 Filed Sep 16, 2021 22:06 UTC |
LAFRANCE JAMES TDirector
|
GrantEmployee Stock Option (Right To Buy) · Derivative | 720 | $0.00 Strike: $4.92 | $0.00 |
DisclosureSEC source: 0001162956-21-000002 · primary_doc.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 720 Underlying: Common Stock · 720 shares Expires 2031-05-06 F2 · derivative.exercise_date: The employee stock option will vest in three equal installments on June 1, 2021, September 1, 2021 and December 1, 2021 Read SEC document |
| May 06, 2021 Filed Sep 16, 2021 22:06 UTC |
LAFRANCE JAMES TDirector
|
GrantCommon Stock | 423 | $0.00 | $0.00 |
DisclosureSEC source: 0001162956-21-000002 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,862 F1 · shares: The restricted stock units will vest in three equal installments on June 1, 2021, September 1, 2021 and December 1, 2021. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 22:12 UTC |
Sandford NicoleDirector
|
GrantCommon Stock | 15,902 | $0.00 | $0.00 |
DisclosureSEC source: 0001849521-21-000001 · primary_doc.xml · nonDerivative · entry 1 Sandford Nicole · CIK 0001849521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,402 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2021, June 1, 2021, September 1, 2021 and December 1, 2021. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 22:03 UTC |
Brooks Sandra ElaineDirector
|
GrantCommon Stock | 14,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001833022-21-000001 · primary_doc.xml · nonDerivative · entry 1 Brooks Sandra Elaine · CIK 0001833022 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,728 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2021, June 1, 2021, September 1, 2021 and December 1, 2021. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 21:57 UTC |
Beechey Robert HarryChief Financial Officer
|
GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 150,000 | $0.00 Strike: $7.40 | $0.00 |
DisclosureSEC source: 0001725914-21-000001 · primary_doc.xml · derivative · entry 1 Beechey Robert Harry · CIK 0001725914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common stock · 150,000 shares Expires 2031-03-19 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 19, 2022. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 21:51 UTC |
Palmieri Valerie BarberDirector · President and CEO
|
GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 450,000 | $0.00 Strike: $7.40 | $0.00 |
DisclosureSEC source: 0001623017-21-000001 · primary_doc.xml · derivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2031-03-19 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 19, 2022. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 21:39 UTC |
COCOZZA NANCY GDirector
|
GrantCommon Stock | 15,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001232953-21-000001 · primary_doc.xml · nonDerivative · entry 1 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,632 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2021, June 1, 2021, September 1, 2021 and December 1, 2021. F2 · balance_after: Total reflects the adjustment of 16,554 shares of common stock previously reported as part of a restricted stock unit grant made on March 19, 2020. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 21:25 UTC |
Jordan Veronica GHDirector
|
GrantCommon Stock | 16,442 | $0.00 | $0.00 |
DisclosureSEC source: 0001381123-21-000001 · primary_doc.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,519 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2021, June 1, 2021, September 1, 2021 and December 1, 2021. F2 · balance_after: Total reflects the adjustment of 17,617 shares of common stock previously reported as part of a restricted stock unit grant made on March 19, 2020. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 21:03 UTC |
LAFRANCE JAMES TDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,412 | $0.00 Strike: $7.40 | $0.00 |
DisclosureSEC source: 0001162956-21-000001 · primary_doc.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,412 Underlying: Common Stock · 15,412 shares Expires 2031-03-19 F3 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2021, June 1, 2021, September 1, 2021 and December 1, 2021. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 21:03 UTC |
LAFRANCE JAMES TDirector
|
GrantCommon Stock | 9,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001162956-21-000001 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,439 F1 · shares: The shares of common stock represent restricted stock units with the contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2021, June 1, 2021, September 1, 2021 and December 1, 2021. F2 · balance_after: Total reflects the adjustment of 21,246 shares of common stock previously reported as part of a restricted stock unit grant made on March 19, 2020. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 21:15 UTC |
SCHREIBER DAVIDDirector
|
GrantCommon Stock | 4,031 | $0.00 | $0.00 |
DisclosureSEC source: 0001255627-21-000001 · primary_doc.xml · nonDerivative · entry 1 SCHREIBER DAVID · CIK 0001255627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,521 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock units will vest in two equal installments on April 1, 2021 and June 1, 2021. F2 · balance_after: Total reflects the adjustment of 17,528 shares of common stock previously reported as part of a restricted stock unit grant made on March 19, 2020. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 21:35 UTC |
SCHREIBER DAVIDDirector
|
SaleCommon Stock | 50,000 | $2.78 | $139,000.00 |
DisclosureSEC source: 0001255627-20-000002 · primary_doc.xml · nonDerivative · entry 1 SCHREIBER DAVID · CIK 0001255627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,018 F1 · shares: The proceeds are intended to cover tax liability for restricted stock units of Aspira Women's Health Inc. received in 2020. F2 · price: The sale reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.75 to $2.85 per share. The reporting person undertakes to provide to Aspira Women's Health Inc., any security holder of Aspira Women's Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:25 UTC |
SCHULER JACK W10% owner
|
PurchaseCommon Stock, par value $0.001 | 2,285,715 | $3.50 | $8,000,002.50 |
DisclosureSEC source: 0000905148-20-000769 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 25,394,517 F1 · ownership.nature: These shares of common stock are directly held by the Jack W. Schuler Living Trust. Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document |
| June 09, 2020 Filed Jun 12, 2020 01:32 UTC |
SCHULER JACK W10% owner
|
OtherWarrants (Right to buy) · Derivative | 730,560 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000905148-20-000694 · form4.xml · derivative · entry 2 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 730,560 shares Expires 2020-06-09 F1 · ownership.nature: These shares of common stock are directly held by the Jack W. Schuler Living Trust. Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document |
| June 09, 2020 Filed Jun 12, 2020 01:32 UTC |
SCHULER JACK W10% owner
|
OtherCommon Stock, par value $0.001 | 730,560 | $1.80 | $1,315,008.00 |
DisclosureSEC source: 0000905148-20-000694 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 23,108,802 F1 · ownership.nature: These shares of common stock are directly held by the Jack W. Schuler Living Trust. Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 17:03 UTC |
FEINBERG LARRY N10% owner
ORACLE PARTNERS LP10% owner
|
OtherWarrants to acquire Common Stock · Derivative | 463,298 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001104659-20-072060 · tm2022328d2_4.xml · derivative · entry 4 FEINBERG LARRY N · CIK 0000926475 · 10% owner ORACLE PARTNERS LP · CIK 0000941901 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 463,298 shares Expires 2020-06-08 F6 · derivative.expiration_date: The original Warrant expiration date was 2/17/2022, which date was accelerated by the Issuer to 6/8/2020 upon notice to the Reporting Persons. F1 · ownership.nature: These securities are owned by Oracle Partners, LP. ("Partners"). F4 · ownership.nature: Larry N. Feinberg serves as the managing member of Oracle Associates, LLC, the general partner of Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the indirect beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund. Mr. Feinberg is the sole shareholder, director and president of Oracle Investment Management, Inc., which serves as investment manager to Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund. F5 · ownership.nature: Each of the Reporting Persons identified in this statement disclaims beneficial ownership of the securities described in this statement, except to the extent of their individual respective pecuniary interest in such securities. The filing of this statement shall not be deemed an admission that any of the Reporting Persons identified in this statement are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any securities specified in this statement other than those directly beneficially owned by them. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 17:03 UTC |
FEINBERG LARRY N10% owner
ORACLE PARTNERS LP10% owner
|
OtherCommon Stock | 463,298 | $1.80 | $833,936.40 |
DisclosureSEC source: 0001104659-20-072060 · tm2022328d2_4.xml · nonDerivative · entry 1 FEINBERG LARRY N · CIK 0000926475 · 10% owner ORACLE PARTNERS LP · CIK 0000941901 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,137,052 F1 · ownership.nature: These securities are owned by Oracle Partners, LP. ("Partners"). F4 · ownership.nature: Larry N. Feinberg serves as the managing member of Oracle Associates, LLC, the general partner of Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the indirect beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund. Mr. Feinberg is the sole shareholder, director and president of Oracle Investment Management, Inc., which serves as investment manager to Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund. F5 · ownership.nature: Each of the Reporting Persons identified in this statement disclaims beneficial ownership of the securities described in this statement, except to the extent of their individual respective pecuniary interest in such securities. The filing of this statement shall not be deemed an admission that any of the Reporting Persons identified in this statement are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any securities specified in this statement other than those directly beneficially owned by them. Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:28 UTC |
Burns James SDirector
|
OtherWarrants to acquire Common Stock · Derivative | 11,250 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001294046-20-000002 · primary_doc.xml · derivative · entry 2 Burns James S · CIK 0001294046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,250 shares Expires 2020-06-09 Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:28 UTC |
Burns James SDirector
|
OtherCommon Stock | 11,250 | $1.80 | $20,250.00 |
DisclosureSEC source: 0001294046-20-000002 · primary_doc.xml · nonDerivative · entry 1 Burns James S · CIK 0001294046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,461 Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:25 UTC |
Jordan Veronica GHDirector
|
OtherWarrants to acquire Common Stock · Derivative | 5,021 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001562762-20-000219 · certent-form4.xml · derivative · entry 2 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,021 shares Expires 2020-06-09 Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:25 UTC |
Jordan Veronica GHDirector
|
OtherCommon Stock | 5,021 | $1.80 | $9,037.80 |
DisclosureSEC source: 0001562762-20-000219 · certent-form4.xml · nonDerivative · entry 1 Jordan Veronica GH · CIK 0001381123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,694 Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:40 UTC |
Palmieri Valerie BarberDirector · President and CEO
|
OtherWarrants to acquire Common Stock · Derivative | 7,531 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001623017-20-000003 · primary_doc.xml · derivative · entry 2 Palmieri Valerie Barber · CIK 0001623017 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,531 shares Expires 2020-06-09 Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:40 UTC |
Palmieri Valerie BarberDirector · President and CEO
|
OtherCommon Stock | 7,531 | $1.80 | $13,555.80 |
DisclosureSEC source: 0001623017-20-000003 · primary_doc.xml · nonDerivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,094 Read SEC document |
| June 02, 2020 Filed Jun 5, 2020 01:54 UTC |
LAFRANCE JAMES TDirector
|
OtherWarrants to acquire stock · Derivative | 5,210 | $0.13 Strike: $1.80 | $651.25 |
DisclosureSEC source: 0001162956-20-000002 · primary_doc.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,210 shares Expires 2020-06-08 Read SEC document |
| June 02, 2020 Filed Jun 5, 2020 01:54 UTC |
LAFRANCE JAMES TDirector
|
OtherCommon Stock | 5,210 | $1.80 | $9,378.00 |
DisclosureSEC source: 0001162956-20-000002 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434,480 Read SEC document |
| June 02, 2020 Filed Jun 10, 2020 00:44 UTC Amendment |
LAFRANCE JAMES TDirector
|
OtherWarrants to acquire Common Stock · Derivative | 5,021 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001162956-20-000003 · primary_doc.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,021 shares Expires 2020-06-08 F1 · derivative.underlying_shares: This amendment is being filed to correct an error in the number of shares of common stock and warrants previously reported, which were inadvertently over-reported in the original Form 4 filing as a result of a transposition of the numbers. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.